Revive TherapeuticsRVVTF -9.68% Market Cap is $10.74 Mil as of Jul. 11, 2026. The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Revive Therapeutics ranks worse than 86.23% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Revive Therapeutics's share price for the quarter that ended in Mar. 2026 was $0.026. Revive Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 435.68 Mil. Therefore, Revive Therapeutics's market cap for the quarter that ended in Mar. 2026 was $11.33 Mil.
Revive Therapeutics's quarterly market cap
declined
from Sep. 2025 ($4.84 Mil) to Dec. 2025 ($3.59 Mil) but then
increased
from Dec. 2025 ($3.59 Mil) to Mar. 2026 ($11.33 Mil).
Revive Therapeutics's annual market cap
declined
from Jun. 2023 ($13.70 Mil) to Jun. 2024 ($3.14 Mil) but then
increased
from Jun. 2024 ($3.14 Mil) to Jun. 2025 ($6.17 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Revive Therapeutics's Enterprise Value for Today is $8.36 Mil.
Revive Therapeutics (OTCPK:RVVTF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Revive Therapeutics Market Cap Related Terms
Revive Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Revive Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revive Therapeutics Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Revive Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Revive Therapeutics's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revive Therapeutics (RVVTF) has a Market Cap of $10.74 Mil as of Jul. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Revive Therapeutics and its competitors. According to the industry distribution chart, Revive Therapeutics ranks #883 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 86.2%.
Is Revive Therapeutics' Market Cap too high?
Revive Therapeutics' current Market Cap is $10.74 Mil. The Drug Manufacturers industry median Market Cap is 214.09. Revive Therapeutics' value of $10.74 Mil is 95% below this industry median. Based on the distribution chart, Revive Therapeutics ranks #883 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Revive Therapeutics' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Revive Therapeutics ranks #883 out of 1024 companies for Market Cap. This places Revive Therapeutics in the lower half of its industry. The industry median Market Cap is 214.09. Revive Therapeutics' value of $10.74 Mil is 95% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.09, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revive Therapeutics's current Market Cap of $10.74 Mil is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Revive Therapeutics and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revive Therapeutics's current Market Cap is $10.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revive Therapeutics stock overvalued right now?
Revive Therapeutics (RVVTF) has a current Market Cap of $10.74 Mil. The current Market Cap is $10.74 Mil and 95% below the Drug Manufacturers industry median of 214.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Revive Therapeutics (RVVTF), the current Market Cap is $10.74 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. The company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVVTF has been successfully added to your 